Media Summary: In this presentation, Robert Lionberger will discuss the GDUFA On September 9, 2022, the U.S. Food and Drug Administration (FDA) hosted a webinar for industry, patient groups, and other ... The purpose of the Jun 13, 2024 listening session was to provide an

Public Meeting Using Methods From Pfdd Guidance 1 And Guidance 2 Meeting 2 - Detailed Analysis & Overview

In this presentation, Robert Lionberger will discuss the GDUFA On September 9, 2022, the U.S. Food and Drug Administration (FDA) hosted a webinar for industry, patient groups, and other ... The purpose of the Jun 13, 2024 listening session was to provide an This video demonstrates how to explain a diagnosis of type Overview of FDA's Patient-Focused Drug Development Initiative Theresa Mullin, PhD Office of the Center Director, Center for Drug ...

Photo Gallery

Public Meeting: Using Methods from PFDD Guidance 1 and Guidance 2 Meeting #2
Public Meeting: Using Methods from PFDD Guidance 1 and Guidance 2 Meeting #1
GDUFA II Training - Pre ANDA Product Development Meetings, Robert Lionberger
GDUFA II Training - Pre ANDA Program Pre Submission Meetings, Robert Lionberger
Public Webinar: Patient-Focused Drug Development Draft Guidance 3
Public Meeting: Optimizing FDA’s Use of and Processes for Advisory Committees (Morning Portion)
Type 2 Diabetes Counselling  - OSCE Guide | Communication Skills | UKMLA | CPSA | SCA Case | PLAB 2
Public Meeting: Patient-Focused Drug Development for Autism (Part 1 of 2)
FDA Patient Focused Drug Development Meeting - Overview of FDA PFDD Initiative
How to Run an Effective Meeting 5 Tips
Sponsored
Sponsored
View Detailed Profile
Public Meeting: Using Methods from PFDD Guidance 1 and Guidance 2 Meeting #2

Public Meeting: Using Methods from PFDD Guidance 1 and Guidance 2 Meeting #2

On July 25, 2022, FDA hosted a

Public Meeting: Using Methods from PFDD Guidance 1 and Guidance 2 Meeting #1

Public Meeting: Using Methods from PFDD Guidance 1 and Guidance 2 Meeting #1

On June 30, 2022, FDA hosted a

Sponsored
GDUFA II Training - Pre ANDA Product Development Meetings, Robert Lionberger

GDUFA II Training - Pre ANDA Product Development Meetings, Robert Lionberger

In this presentation, Robert Lionberger will discuss the GDUFA

GDUFA II Training - Pre ANDA Program Pre Submission Meetings, Robert Lionberger

GDUFA II Training - Pre ANDA Program Pre Submission Meetings, Robert Lionberger

The pre-ANDA program is new in GDUFA

Public Webinar: Patient-Focused Drug Development Draft Guidance 3

Public Webinar: Patient-Focused Drug Development Draft Guidance 3

On September 9, 2022, the U.S. Food and Drug Administration (FDA) hosted a webinar for industry, patient groups, and other ...

Sponsored
Public Meeting: Optimizing FDA’s Use of and Processes for Advisory Committees (Morning Portion)

Public Meeting: Optimizing FDA’s Use of and Processes for Advisory Committees (Morning Portion)

The purpose of the Jun 13, 2024 listening session was to provide an

Type 2 Diabetes Counselling  - OSCE Guide | Communication Skills | UKMLA | CPSA | SCA Case | PLAB 2

Type 2 Diabetes Counselling - OSCE Guide | Communication Skills | UKMLA | CPSA | SCA Case | PLAB 2

This video demonstrates how to explain a diagnosis of type

Public Meeting: Patient-Focused Drug Development for Autism (Part 1 of 2)

Public Meeting: Patient-Focused Drug Development for Autism (Part 1 of 2)

On May 4, 2017, FDA hosted a

FDA Patient Focused Drug Development Meeting - Overview of FDA PFDD Initiative

FDA Patient Focused Drug Development Meeting - Overview of FDA PFDD Initiative

Overview of FDA's Patient-Focused Drug Development Initiative Theresa Mullin, PhD Office of the Center Director, Center for Drug ...

How to Run an Effective Meeting 5 Tips

How to Run an Effective Meeting 5 Tips

Learn How to Run an Effective